© 2009 CSTS: The Cardiovascular Surgical Translational Study Using the Centers for Disease Control and Prevention’s National Healthcare Safety Network.

Slides:



Advertisements
Similar presentations
Jan Bazner-Chandler RN, MSN, CNS, CPNP
Advertisements

PART II CATHETER RELATED BLOOD STREAM INFECTION (CR-BSI) CATHETER RELATED URINARY TRACT INFECTIN (CR-UTI)
Central Line Bundle Education
Infection Control: IV Drug Administration
C. difficile Lab ID Reporting in NHSN Stanley Ostrawski RN, MS, MT(ASCP), CIC Infection Preventionist Consultant.
Blood Culture. Bacteremia: Types  Transient: Disruption of mucosal surfaces (dental or surgical procedures)  Intermittent: Associated with abscesses.
Anti-Microbial Capped Central Line and Infection Control.
Surveillance Branch, DHQP
Infusion Therapy.
Central line Bundle Education National Patient Safety Goal
Tennessee Center for Patient Safety Data Reporting.
Hospital Surveillance. Impact of infectious diseases  IDs are considered to be the leading cause of death  Mass population movement  Emerging and re-emerging.
Findings from the Virginia Department of Health (VDH) 2010 Central Line-Associated Bloodstream Infection (CLABSI) Data Audit Project Andrea Alvarez,
Health Care Associated Infections in Massachusetts Acute Care Hospitals Update: Fiscal Year 2012 July 1, 2011-June 30, 2012 Released June 2013.
Bloodstream Infections related to Central Lines
Research and analysis by Avalere Health Hospitals Demonstrate Commitment to Quality Improvement October 2012.
Only 5-15% of blood cultures are (+) in febrile patients A.Types of bacteremia: Extravascular via the lymphatic's Intravascular: i.e. CVC infections B.Types.
Certification of Central Venous Lines Georgia Health Sciences Medical Center Augusta, Georgia November 13, 2012.
Eunice Huang, MD, MS APSA Education Day Palm Desert, CA May 22, 2011
 Introduced in early 1980s  Allow medications to be delivered directly into larger veins  Less likely to clot  Can be left in for longer periods of.
 To decrease the rate of central line associated blood stream infections  To increase knowledge on the purpose and effectiveness of chlorhexidine gluconate.
Standard and Expanded Precautions
Central Lines: All you ever wanted to know Allison Ballantine, MD Assistant Professor of Pediatrics Medical Director, Integrated Care Service Director.
Katherine Allen-Bridson, RN, BSN, MScPH, CIC, Centers for Disease Control and Prevention National Center for Emerging and Zoonotic Infectious Diseases.
Strategies to Reduce the Incidence of Central Line-Associated Bloodstream Infections Wendy Kaler MPH, CIC Manager of Infection Control Saint Francis Memorial.
Indiana Healthcare Associated Infection Initiative Kickoff.
Originally Created By: Sheila Elliott MN, RN Revised By: Tina Haayer, RN, BScN.
Using and Sharing Findings from Surveillance: Rates, Ratios Proportions, Data Display & OUTBREAKS Russ Olmsted, MPH, CIC
Comparative Effectiveness Grant Toward Eliminating Central Line Associated Blood Stream Infections.
Bacterial Infection of Cardiovascular system By Dr. Humodi A. Saeed Associate Prof. of Medical Microbiology College of Medical Laboratory Science Sudan.
HEALTH CARE ASSOCIATED INFECTION دکترافشین محمد علیزاده متخصص عفونی عضوهیئت علمی دانشگاه علوم پزشکی شهیدبهشتی بیمارستان آیت ا...طالقانی.
Healthcare Associated Infections in 2014 Acute Care Hospitals Alfred DeMaria, Jr., M.D. Medical Director, State Epidemiologist Bureau of Infectious Disease.
creating an integrated clabsi prevention program
Here at TMC. 2 3 Healthcare Associated Infection Definition: –A localized or systemic condition resulting from an adverse reaction to the presence of.
Illinois Healthcare-Associated Infections (HAI) Plan Mary Fornek January 21, 2010 Metropolitan Chicago Healthcare Council.
NHSN N ATIONAL H EALTHCARE S AFETY N ETWORK Catheter-Associated Urinary Tract Infection (CAUTI) ELSA SANTOS-CRUZ, CIC MOUNT SINAI MEDICAL CENTER (INFECTION.
Division of Public Health CRE Surveillance and Prevention of Transmission in Healthcare Settings Gwen Borlaug, CIC, MPH Coordinator, Healthcare-Associated.
Reducing Adult Central Line Related Bloodstream Infections.
Care of patient with CVC
By Denise Dixon. Catheter related blood stream infections (CRBSI) is a problem in our healthcare. Many clinicians and patients struggle to over come this.
Cardiovascular (Blood Vessels) & Respiratory System Diagrams for Test.
Blood Vessels Study Guide.
Infusion Therapy.
Clinical Trials for Bloodstream Infection / Infective Endocarditis G. Ralph Corey, MD Vance Fowler, MD Duke Clinical Research Institute April 15, 2004.
ICU TO PREVENT CENTRAL LINE ASSOCIATED BLOODSTREAM INFECTIONS.
Blood Flow Through the Heart. Right Lung Left Lung.
Cat Circulatory System. Brachiocephalic vein External jugular vein Common carotid artery Subclavian artery and vein.
Human Circulatory System Major Vessels Starred Slides for Quizzes.
MICROBIOLOGICAL EPIDEMIOLOGY OF RESPIRATORY SPECIMENS IN ICU PATIENTS Dr Farooq Cheema, Dr Waseem Tariq, Dr Raja Ishtiaq, Dr Tabassum Qureshi, Dr Vincent.
Protection Against Catheter- related Infections Dariush Abtahi MD Anesthesiologist.
Department of Infectious Diseases, Infection Control and Employee Health, University of Texas MD Anderson Cancer Center, Houston, TX, USA (Prof I Raad.
Lines and catheters and cannulas (oh my!) or How hard should I tug on this thread?
Standard Vocabulary Implementation Experience from CDC Partners and Programs PHIN Conference August 25, :30 a.m. – 12 noon.
Artery and Vein. Artery and Vein Vessel Man.
Prevention of Catheter Related Infections Dr.E.Shojaei T.U.M.S Jan 2016.
Blood Vessels.
Right brachiocephalic vein
Complications of Central Line Insertion
Journey to Improvement
Title of the Poster Presentation Placed Here
Bio 209 Arteries and Veins.
Introduction to CAUTI and CLABSI Initiatives
HAI August 30, 2017.
HAI January 24, 2018.
Changes to 10A NCAC 41A May 5, 2018.
Dissection for 5/5: turn in thoracic papers
HAI Sept. 25, 2017.
Internal jugular vein Common carotid artery External jugular vein
Human Vessels.
Chapter 9 Preventing Infection Associated with Intravascular Therapy
Presentation transcript:

© 2009 CSTS: The Cardiovascular Surgical Translational Study Using the Centers for Disease Control and Prevention’s National Healthcare Safety Network (NHSN) for CLABSI Surveillance in Adult ICUs

© 2009 Learning Objectives To review the NHSN definition of a central line To review the NHSN definition of bloodstream infection (BSI) To review the NHSN denominator definition for calculating CLABSI rates in adult ICUs

© 2009 What is a Central Line? An intravascular catheter that terminates at or close to the heart or in one of the great vessels which is used for infusion, withdrawal of blood, or hemodynamic monitoring. – Great vessel: aorta, pulmonary artery, superior vena cava, inferior vena cava, brachiocephalic veins, internal jugular veins, subclavian veins, external iliac veins, and common femoral veins – Infusion: introduction of a solution through a blood vessel via a catheter lumen The location of the insertion site and type of device are NOT relevant

© 2009 What is a Central Line? Non-tunneled central lines Tunneled central lines Introducers Implanted ports Hemodialysis catheters Peripherally inserted central catheters (PICCs) Femoral artery catheter Pacemakers Implanted cardiac defibrillators Radial, dorsalis pedis, brachialis, ulnar arterial lines The following are examples of central lines, as long as they terminate at or close to the heart or in one of the great vessels NOTE: This list is not inclusive The following are examples of devices that are not central lines NOTE: This list is not inclusive

© 2009 Data That Need to Be Collected For determining CLABSI rate – Numerator: number of CLABSIs – Denominator: number of central line-days – Expressed as a rate of X CLABSI/1,000 central line days #CLABSI/# central line days X 1000 For determining the Central Line Utilization Ratio – Numerator: number of central line-days – Denominator: number of patient-days

© 2009 The Numerator

© 2009 Definition of BSI in Adults Criterion 1: Patient has a recognized pathogen cultured from one or more blood cultures AND Organism cultured from blood is not related to an infection at another site.

© 2009 Definition of BSI in Adults Criterion 2: Patient has at least one of the following signs or symptoms: fever (>38oC), chills, or hypotension AND Signs and symptoms and positive laboratory results not related to an infection at another site AND Common skin contaminant is cultured from two or more blood cultures drawn on separate occasions. – Blood from ≥ 2 blood draws collected within 2 days

© 2009Microbiology Diphtheroids: Corynebacterium spp. Bacillus spp. – Not B. anthracis Propionibacterium spp. Coagulase-negative staphylococci – Including S. epidermidis Viridans group streptococci Aerococcus spp. Micrococcus spp. S. aureus Enterococcus spp. E. coli Pseudomonas spp. Klebsiella spp. Enterobacter spp. Citrobacter spp. Serratia marcescens Acinetobacter spp. Candida spp. Examples of Common Skin Contaminants (not inclusive) Examples of Common Recognized Pathogens (not inclusive)

© 2009 When Are Organisms the Same? If isolates are identified to the species level in one culture, and with only a descriptive name (i.e., to the genus level) from the other culture If isolates are speciated but no antibiograms are done or done for only one of the isolates

© 2009 When Are Organisms Not the Same? If isolates have different antibiograms for two or more antimicrobial agents – For the purpose of NHSN antibiogram reporting, the category interpretation of intermediate (I) should NOT be used to distinguish whether two organisms are different

© 2009 Timing of CLABSI Central line-associated BSI – A central line was in place at the time of onset of the event OR – A central line was in place within 48 hours before onset of the event There is no minimum period of time that the central line must be in place in order for the BSI to be considered central line-associated

© 2009 Location of Attribution The patient care area where the event became evident – CLABSIs in patients with central lines placed in non- inpatient areas (emergency department, operating room) are attributed to the inpatient unit – Transfer Rule: If a CLABSI develops within 48 hours of transfer from one inpatient location to another in the same facility, the infection is attributed to the transferring location

© 2009 Entering Numerator Data The Primary Bloodstream Infection (BSI) Form (CDC ) is used to collect and report each CLABSI that is identified during the month Other data requested – Specific criteria met for identifying the primary BSI – Whether the patient died – Causative organisms – Organisms’ antimicrobial susceptibilities.

© 2009 The Denominator

© 2009 Collecting Central Line Days For ICUs, the number of patients with one or more central lines of any type is collected daily, at the same time each day, and then summed – The total is reported for the month on the Denominators for Intensive Care Unit (ICU)/Other Locations (Not NICU or Specialty Care Area (SCA)) (CDC ).

© 2009 Collecting Central Line Days: Multiple Lines in an ICU Patient If a patient has more than one central line (permanent or temporary) on a given day, count the day as only one central line day.

© 2009 Action Items Verify that the infection control group in your institution is collecting CLABSI rates based on the NHSN definitions for what is a central line and what is a BSI Verify that both catheters days and patient days are being collected correctly in the ICU(s)

© 2009References National Healthcare Safety Network (NHSN): Overview of the Patient Safety Component, Device-associated module (CLASI) – SC_CLABScurrent.pdf SC_CLABScurrent.pdf